Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 63187-943

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 63187-943). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

63187-943-30 (Valsahctz 80 125mg)

Packaging label for Valsartan and Hydrochlorothiazide 80 mg / 12.5 mg film-coated tablets by Proficient Rx LP. The bottle contains 30 tablets. The label notes the product ID PV094330 and indicates the manufacturer as Alembic Pharmaceuticals Limited, Gujarat, India. The tablets are described as light orange, oval-shaped, debossed with 'L235' on one side, and plain on the other.*

FDA Label Image

Figure 1 (Valsahctz Figur1)

A line graph titled 'Figure 1: Probability of Achieving Systolic Blood Pressure <140 mm Hg at Week 8' showing the relationship between baseline systolic blood pressure (SBP) in mmHg (140 to 180) on the x-axis and the percentage achieving SBP <140 mmHg on the y-axis (0 to 100%). The graph compares four groups: Valsartan and hydrochlorothiazide tablets 320/25 mg (circles), Valsartan 320 mg (triangles), Hydrochlorothiazide 25 mg (squares), and placebo (crosses). The combined tablets group shows the highest percentage across baseline SBP values.*

FDA Label Image

Figure 2-3-4 (Valsahctz Figure2 3 4)

Three line graphs showing the probability of achieving target blood pressure levels at Week 8 for Valsartan and Hydrochlorothiazide tablets 320/25 mg compared to Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo. The first graph depicts diastolic blood pressure <90 mmHg against baseline DBP (mmHg). The second graph shows systolic blood pressure <130 mmHg against baseline SBP (mmHg). The third graph presents diastolic blood pressure <80 mmHg versus baseline DBP (mmHg).*

FDA Label Image

Structure (Valsahctz Hctz)

Chemical structure of Valsartan and Hydrochlorothiazide showing the molecular arrangement of atoms including chlorine, sulfur, nitrogen, oxygen, and other components characteristic of the combined active ingredients.*

FDA Label Image

Structure (Valsahctz Valsa)

Chemical structure diagram of Valsartan, the active ingredient in the combined Valsartan and Hydrochlorothiazide medication. The structure displays the molecular arrangement characteristic of Valsartan.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.